Navigation Links
Shire plc: Continued Strong Product Sales Performance in Q3: On Track to Deliver Significant 2011 Earnings Growth
Date:10/28/2011

mber September 30, 30, 30, 30, 2011 2010 2011 2010 Millions Millions Millions Millions Share awards(1) 3.2 3.6 3.9 8.9 Convertible bonds 2.75% due 2014(2) - 33.2 - -

  1. Certain stock options have been excluded from the calculation of diluted EPS because (a) their exercise prices exceeded Shire plc's average share price during the calculation period or (b) satisfaction of the required performance/market conditions cannot be measured until the conclusion of the performance period.
  2. For the three month period ended September 30, 2010 the ordinary shares underlying the convertible bonds have not been included in the calculation of the diluted weighted average number of shares, as the effect of their inclusion would be anti-dilutive.


 

Unaudited US GAAP results for the three months to September 30, 2011

Selected Notes to the Financial Statements

(2)  Analysis of revenues

3 months to September 30, 2011 2010 2011 2011 % % of total $M $M change Revenue Net product sales: Specialty Pharmaceutical ("SP") ADHD VYVANSE 199.7 151.2 32% 18% ADDERALL XR 149.9 99.7 50% 14% INTUNIV 56.1 37.3 50% 5% EQUASYM 5.1 5.7 -11% <1% DAYTRANA - 14.7 n/a n/a 410.8 308.6 33% 38% GI LIALDA/MEZAVANT 89.7 76.0 18% 8% PENTASA 55.9 57.1 -2% 5% RESOLOR 1.5 - n/a <1% 147.1 133.1 11% 14% General products FOSRENOL 40.5 45.2 -10% 4% XAGRID(R) 23.3 20.5 14% 2% CARBATROL(R) 12.3 20.3 -39% 1% 76.1 86.0 -12% 7% Other product sales 24.0 25.3 -5% 2% Total SP product sales 658.0 553.0 19% 61% Human Genetic Therapies ("HGT") REPLAGAL 129.0 92.1 40% 12% ELAPRASE 109.6 96.8 13% 10% VPRIV 64.6 49.5 31% 6% FIRAZYR 7.2 2.9 148% <1% Total HGT product sales 310.4 241.3 29% 28% Regenerative Medicine ("RM") DERMAGRAFT 50.0 - n/a 5% Total RM product sales 50.0 - n/a 5% Total product sales 1,018.4 794.3 28% 94% Royalties: ADDERALL XR 22.9 18.0 27% 2% 3TC and ZEFFIX 17.3 40.6 -57% 2% FO
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Related biology technology :

1. NHS Northamptonshire Chief Executive John Parkes Accepts Visiting Professorship
2. FDA Approves Shires FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE)
3. Shires Quarterly Revenues Grow by 25% to $1 Billion for the First Time
4. Shire Files Lawsuits Against Watson and Roxane for Infringement of VYVANSE(R) (lisdexamfetamine dimesylate) Patents
5. Shire Presents Data at ACMG for Fabry and Gaucher Patients Who Switched to Replagal® (agalsidase alfa) and VPRIV® (velaglucerase alfa for injection)
6. Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules as Adjunctive Treatment in Major Depressive Disorder
7. Shire plc: Continued Excellent Performance in Q3, Full Year Earnings Expectations Increased, New Value in Pipeline Emerging
8. Shire Announces Results of the Tender Offer for Movetis NV and Commencement of Squeeze-Out Tender Period
9. Reportlinker Adds Shire plc: PharmaVitae Profile
10. Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease
11. Shire plc - Statement re ProAmatine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  Verenium Corporation (Nasdaq: VRNM ), a ... commercialization of high-performance enzymes, today announced that ... at two upcoming conferences. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO ... Second Annual Marcum LLP Microcap Conference on Thursday, May ... York City.  The presentation is scheduled to begin at ...
(Date:5/23/2013)... Korea , May 23, 2013 ... SillaJen, Inc., a private biotherapeutics and contract research ... biological products for cancer, announced today a publication ... patients treated with the oncolytic and immunotherapeutic vaccinia ... This research was published in the May 15 ...
(Date:5/23/2013)... African Ancestry , Inc., the ... African descent, today announced new product enhancements to ... all races, myDNAmix determines various ancestries included in ... Americas (Native American), East Asia, West Sub-Saharan Africa, ... Originally launched in late 2011, the enhanced product ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Bed bugs ... the university had already confirmed it. Meanwhile, My Cleaning Products ... bed bug victims fight the pests without using harmful chemical ... on May 15, 2013, the affected building was actually a ... being infested was said made on May 13 and bed ...
Breaking Biology Technology:Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 3Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2
... to Drink,Suite of Nutritional Supplements to Provider Services, Inc. to be ... ... 5 Millennium Biotechnologies,Inc., wholly owned subsidiary of Millennium Biotechnologies Group, ... an,amendment of it,s November 9th 2007 Master Purchase Contract with Provider,Services, ...
... for Growth in 2009 and ... ... Monsanto,s international,seed brands serve as an ideal launching pad that positions ... ramp-up,speed, Brett Begemann, Monsanto,s executive vice president of global,commercial, will tell ...
... for Mass Spectrometry ... Denver, June 2-5, 2008-, EMERYVILLE, Calif., June 5 ... it has developed a novel analytical,2-dimensional liquid chromatography mass ... sensitive,automated quantification of the active pharmaceutical compounds of MF101,the ...
Cached Biology Technology:Millennium Biotechnologies Announces an Increased Annualized Purchase Commitment Totaling $5.8M from Provider Services, Inc. 2Millennium Biotechnologies Announces an Increased Annualized Purchase Commitment Totaling $5.8M from Provider Services, Inc. 3Monsanto's Industry-Leading Seed Position Creates Accelerated Biotech Trait Opportunity in Latin America 2Monsanto's Industry-Leading Seed Position Creates Accelerated Biotech Trait Opportunity in Latin America 3Monsanto's Industry-Leading Seed Position Creates Accelerated Biotech Trait Opportunity in Latin America 4Bionovo Develops a High Throughput LC-MS/MS Method for Simultaneous Quantification of Multiple Bioactive Compounds 2Bionovo Develops a High Throughput LC-MS/MS Method for Simultaneous Quantification of Multiple Bioactive Compounds 3
(Date:5/22/2013)... in cellular DNA can endanger the whole organism, as ... at Ludwig-Maximilians-Universitaet (LMU) in Munich now report how byproducts ... helix. , The DNA in our cells controls the ... bodies. The instructions for this are encoded in the ... the bases adenine (A), cytosine (C), guanine (G) and ...
(Date:5/22/2013)... details on how climate change will affect interactions between ... Journal of Animal Ecology . This knowledge, they ... policymakers of how species are likely to be impacted ... growing recognition among biologists that climate change is affecting ... is going to have very important consequences for the ...
(Date:5/22/2013)... the biodiversity of pollinating insects and wild plants have ... , Researchers led by the University of Leeds and ... evidence of dramatic reductions in the diversity of species ... and 1980s. , But the picture brightened markedly after ... losses among bees, hoverflies and wild plants. ...
Breaking Biology News(10 mins):DNA damage: The dark side of respiration 2UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3
... tissue as well as eradicating the tumour it is ... often causing nasty side effects. A new development ... accurate treatment for cancerous tumours by using real-time images ... combining radiation treatment with non-invasive MR imaging, would be ...
... release is available in French . ... the chilli cook-off, usually has a key secret ingredient, ... crucial proteins, which change the dynamics of cells from ... involving McGill University, the Research Institute of the McGill ...
... . , Montreal, May 19th 2009 - Cocaine ... its abuse has become widespread since the end of the ... about its effects on the human brain or the mechanisms ... Marco Leyton, of the Montreal Neurological Institute (MNI), McGill University ...
Cached Biology News:Proteomics: Finding the key ingredients of disease 2Cocaine: Perceived as a reward by the brain? 2
Incorporating the innovative InGaAs detection system the Cary 6000i is the worlds most advanced UV-Vis-NIR spectrophotometer delivering superior signal to noise performance and outstanding sensitivit...
ABI 432 Resins • Gln(Trt) Peptide Synthesis Column...
The E. coli Expression System with Gateway Technology is designed to create E. coli expression clones containing the T7 promoter. The expression clones are ready for transformation and expression in ...
...
Biology Products: